Mark Smith

Mark Douglas Smith currently serves as Independent Director at Teladoc Health, Inc. and Phreesia, Inc. since 2018, Director at The Commonwealth Fund since 2015, Co-Secretary, Treasurer & Director at The Institute for Healthcare Improvement since 2013, Independent Director at Jazz Pharmaceuticals Plc since 2020, Director at Prealize Health, Inc., Professor at The University of California, San Francisco since 1994, Member of the National Academy of Medicine (United States), Advisor at HEALTH VELOCITY MGMT LLC, and Member of Health Affairs.
Former roles include President & Chief Executive Officer at California HealthCare Foundation from 1996 to 2013, Director at Concerto Health Services, Inc., Director-National Business Group at National Committee for Quality Assurance, Executive Vice President at The Henry J.
Kaiser Family Foundation, Assistant Professor at The Johns Hopkins University, Principal at Annals of Internal Medicine, and Board Member at Archstone Foundation from 1999 to 2019.
Education includes an MBA from The Wharton School of the University of Pennsylvania in 1989, a doctorate from The University of North Carolina at Chapel Hill in 1983, and an undergraduate degree from Harvard College in 1979.